Trial · NCT07467421
"Effectiveness of Physical Therapy Added to Transforaminal Injection in Lumbar Radicular Pain"
NCT07467421, Not applicable, Completed, Ankara Training and Research Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. "Effectiveness of Physical Therapy Added to Transforaminal Injection in Lumbar Radicular Pain". Trials, record NCT07467421. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07467421
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- "Effectiveness of Physical Therapy Added to Transforaminal Injection in Lumbar Radicular Pain"
- NCT number
- NCT07467421
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 76 participants, actual
- Lead sponsor
- Ankara Training and Research Hospital
- Conditions
- Lumbar Disc Herniation With Radiculopathy, Low Back Pain (LBP)
- Interventions
- TFESE, TFESE+ CONVENTIONAL PHYSIOTHERAPY
- First posted
- 2026-03-12
- Last updated
- 2026-03-31
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Pain Intensity measured by the Numeric Rating Scale (NRS) | Baseline, 1 hour post-injection, 1 month, and 3 months. | The Numeric Rating Scale (NRS) is an 11-point scale used to assess pain intensity, where 0 represents "no pain" and 10 represents "the worst possible pain." Higher scores indicate greater pain severity. |
| Secondary | Change in Functional Disability measured by the Oswestry Disability Index (ODI) | Baseline, 1 month, and 3 months. | The ODI is a questionnaire used to measure a patient's functional disability for low back pain. It contains 10 topics. Each item is scored 0-5. The total score ranges from 0 to 100, where higher scores indicate more severe disability. |
| Secondary | Change in Depression Levels measured by the Beck Depression Inventory (BDI) | Baseline and 3 months. | The BDI is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression. Each item is scored 0-3. Total scores range from 0 to 63; higher scores indicate higher levels of depression. |
| Secondary | Change in Neuropathic Pain Presence measured by the DN4 (Douleur Neuropathique 4) Questionnaire | Baseline, 1 month, and 3 months. | The DN4 is a screening tool for neuropathic pain consisting of 10 items. A score of 4/10 or higher suggests neuropathic pain. It helps distinguish nociceptive pain from neuropathic pain. |
| Secondary | Change in Spinal Range of Motion (ROM) | Baseline, 1 hour post-injection, 1 month, and 3 months. | Clinical measurement of the lumbar spine flexibility (e.g., using the Schober test or similar clinical assessment) to evaluate functional improvement. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07467421
GET https://conductscience.org/api/trials/v1/NCT07467421/registered